wr 1065 has been researched along with Colorectal Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baulch, JE; Coleman, MC; Dziegielewski, J; Goetz, W; Grdina, DJ; Morgan, WF; Murley, JS; Spitz, DR | 1 |
| Grdina, DJ; Kataoka, Y; Li, JJ; Miller, RC; Murley, JS; Woloschak, G | 1 |
| Baker, KL; Diamond, AM; Grdina, DJ; Kataoka, Y; Morgan, WF; Murley, JS | 1 |
3 other study(ies) available for wr 1065 and Colorectal Cancer
| Article | Year |
|---|---|
WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability.
Topics: Amifostine; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Genomic Instability; Green Fluorescent Proteins; Humans; Mercaptoethylamines; Micronucleus Tests; Radiation Tolerance; Radiation-Protective Agents; Superoxide Dismutase; X-Rays | 2008 |
SOD2-mediated effects induced by WR1065 and low-dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells.
Topics: Adaptation, Physiological; Cell Line, Tumor; Colorectal Neoplasms; Humans; Mercaptoethylamines; Micronuclei, Chromosome-Defective; Radiation-Protective Agents; Reactive Oxygen Species; Superoxide Dismutase; Superoxides | 2011 |
Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha.
Topics: Amifostine; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Humans; Mercaptoethylamines; Radiation Tolerance; Radiation-Protective Agents; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2007 |